Exclusive details on Silo Wellness’ proposed acquisition of Dyscovry Science, a company that, unlike most of its peers in the psychedelics space, which focus on mental health issues, is targeting a physiological condition: irritable bowel syndrome.
Psychedelics Co. Silo Wellness To Acquire Dyscovry Science, Seeking To Leverage Its Govt. Partnerships
